Bank of Montreal
URGN icon

Bank of Montreal’s UroGen Pharma URGN Stock Holding History

Bank of Montreal’s Portfolio URGN Stock Details URGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-534
Closed -$10K – 4893
2021
Q1 		$10K Sell
534
-2,528
-83% -$53.7K ﹤0.01% 4383
2020
Q4 		$65K Buy
3,062
+1,923
+169% +$40.3K ﹤0.01% 3817
2020
Q3 		$23K Sell
1,139
-619
-35% -$14K ﹤0.01% 3779
2020
Q2 		$42K Buy
1,758
+1,444
+460% +$35.3K ﹤0.01% 3509
2020
Q1 		$5K Sell
314
-2,145
-87% -$57.9K ﹤0.01% 3694
2019
Q4 		$82K Buy
2,459
+523
+27% +$14.3K ﹤0.01% 3593
2019
Q3 		$46K Buy
1,936
+372
+24% +$12.2K ﹤0.01% 3664
2019
Q2 		$56K Buy
+1,564
New +$57.7K ﹤0.01% 3639

Other funds holding URGN

MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
ZCA
Zeke Capital Advisors Berwyn, Pennsylvania $1.53B AUM 17.37% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
HCM
Horton Capital Management Philadelphia, Pennsylvania $44.9M AUM 24.87% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of Montreal's URGN Position: Q2 2021 in Review

Bank of Montreal sold out of UroGen Pharma (URGN) in Q2 2021, closing a stake of 534 shares — an estimated $10K sold.

Bank of Montreal first reported a position in URGN in Q2 2019 and held it in 8 quarters. The position peaked at $82K in Q4 2019. 82 funds tracked by Wall St. Rank hold URGN as of Q2 2021.

  • Bank of Montreal reported no remaining UroGen Pharma position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 534 UroGen Pharma shares in Q2 2021, an estimated $10K.
  • Bank of Montreal first reported a position in UroGen Pharma in Q2 2019 and held it in 8 quarters.
  • Bank of Montreal's UroGen Pharma position peaked at $82K in Q4 2019.
  • 82 funds tracked by Wall St. Rank held UroGen Pharma as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.